Table 10.
Minimum inhibitory concentration in μg mL−1 of the compounds 88a–88l.
| Compounds | Sa | Se | Ml | Bc | Ec | Pa | Kp | An | Af |
|---|---|---|---|---|---|---|---|---|---|
| 88a | 31.25 | 31.25 | 15.62 | 62.5 | 31.25 | 31.25 | 15.62 | 62.5 | 31.25 |
| 88b | 125 | 62.5 | 31.25 | 125 | 62.5 | 125 | 31.25 | 125 | 125 |
| 88c | 125 | 62.5 | 125 | 125 | 62.5 | 62.5 | 31.25 | 125 | 125 |
| 88d | 62.5 | 31.25 | 31.25 | 31.25 | 62.5 | 62.5 | 31.25 | 125 | 62.5 |
| 88e | 15.62 | 15.62 | 7.81 | 15.62 | 15.62 | 7.81 | 7.81 | 31.25 | 15.62 |
| 88f | 62.5 | 31.25 | 31.25 | 31.25 | 62.5 | 125 | 31.25 | 125 | 62.5 |
| 88g | 15.62 | 7.81 | 7.81 | 7.81 | 15.62 | 7.81 | 7.81 | 31.25 | 7.81 |
| 88h | 31.25 | 15.62 | 15.62 | 15.62 | 15.62 | 15.62 | 7.81 | 31.25 | 15.62 |
| 88i | 15.62 | 7.81 | 3.9 | 7.81 | 7.81 | 15.62 | 7.81 | 15.62 | 7.81 |
| 88j | 31.25 | 31.25 | 15.62 | 31.25 | 31.25 | 62.5 | 15.62 | 125 | 31.25 |
| 88k | 62.5 | 62.5 | 31.25 | 31.25 | 62.5 | 125 | 31.25 | 125 | 125 |
| 88l | 31.25 | 15.62 | 15.62 | 15.62 | 31.25 | 15.62 | 7.81 | 31.25 | 15.62 |
| Ciprofloxacin | 15.62 | 7.81 | 7.81 | 7.81 | 15.62 | 7.81 | 3.9 | - | - |
| Ketoconazole | - | - | - | - | - | - | - | 15.62 | 7.81 |
Sa: Staphylococcus aureus ATCC 9144; Se: Staphylococcus epidermidis ATCC 155; Ml: Micrococcus luteus ATCC 4698; Bc: Bacillus cereus ATCC 11778; Ec: Escherichia coli ATCC 25922; Pa: Pseudomonas aeruginosa ATCC 2853; Kp: Klebsiella pneumoniae ATCC 11298, An: Aspergillus niger ATCC 9029; Af: Aspergillus fumigatus ATCC 46645.